Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants

25 May 2022

Abstract excerpt

The new coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic, which so far has caused over 6 million deaths in 2 years, despite new vaccines and antiviral medications. Drug repurposing, an approach for the potential application of existing pharmaceutical products to new therapeutic indications, could be an effective strategy to obtain quick answers to medical emergencies. Following a virtual...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to PARP inhibition in cancer therapy
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35614039
DOI: 10.1038/s41419-022-04961-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsPMID 35614039Read ↗

Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variantsSemantic proximity Read ↗

Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/LSemantic proximity Read ↗

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host CellsSemantic proximity Read ↗

Structure, function and variants analysis of the androgen-regulated <i>TMPRSS2</i> , a drug target candidate for COVID-19 infectionSemantic proximity Read ↗

17β‐estradiol reduces SARS‐CoV‐2 infection in vitroSemantic proximity Read ↗

Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry PerspectiveSemantic proximity Read ↗

The Pan-African Natural Products Library Compounds Oleanolic Acid, Poinsettifolin B, and Rhuschalcone III Disrupt SARS-CoV-2 Spike-Host ACE2 Interactions and SARS-CoV-2 ReplicationSemantic proximity Read ↗

TMPRSS2 Transcriptional Inhibition as a Therapeutic Strategy for COVID-19 <strong> </strong>Semantic proximity Read ↗

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity Read ↗

Tripartite combination of potential pandemic mitigation agents: Vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2 targets in human cells.Semantic proximity Read ↗

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19Semantic proximity Read ↗

Use of Antiandrogens as Therapeutic Agents in COVID-19 PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.